NO20055616D0 - Formulation that provides an antimicrobial drug that is effective against organisms that are normally resistant to the drug - Google Patents

Formulation that provides an antimicrobial drug that is effective against organisms that are normally resistant to the drug

Info

Publication number
NO20055616D0
NO20055616D0 NO20055616A NO20055616A NO20055616D0 NO 20055616 D0 NO20055616 D0 NO 20055616D0 NO 20055616 A NO20055616 A NO 20055616A NO 20055616 A NO20055616 A NO 20055616A NO 20055616 D0 NO20055616 D0 NO 20055616D0
Authority
NO
Norway
Prior art keywords
drug
formulation
provides
effective against
against organisms
Prior art date
Application number
NO20055616A
Other languages
Norwegian (no)
Other versions
NO20055616L (en
Inventor
James E Kipp
Joseph Chung Tak Wong
Mark J Doty
Christine L Rebbeck
Chong-Son Sun
Pavlos Papadopoulos
Barrett E Rabinow
Randy White
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of NO20055616D0 publication Critical patent/NO20055616D0/en
Publication of NO20055616L publication Critical patent/NO20055616L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20055616A 2003-04-29 2005-11-28 Formulation that provides an antimicrobial drug that is effective against organisms that are normally resistant to the drug NO20055616L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46635403P 2003-04-29 2003-04-29
PCT/US2004/013268 WO2004096180A1 (en) 2003-04-29 2004-04-29 Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug

Publications (2)

Publication Number Publication Date
NO20055616D0 true NO20055616D0 (en) 2005-11-28
NO20055616L NO20055616L (en) 2006-01-25

Family

ID=33418369

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055616A NO20055616L (en) 2003-04-29 2005-11-28 Formulation that provides an antimicrobial drug that is effective against organisms that are normally resistant to the drug

Country Status (11)

Country Link
EP (1) EP1617818A1 (en)
JP (1) JP2006525345A (en)
KR (1) KR20060015553A (en)
CN (1) CN1794975A (en)
AU (1) AU2004234003A1 (en)
BR (1) BRPI0409929A (en)
CA (1) CA2523151A1 (en)
MX (1) MXPA05011607A (en)
NO (1) NO20055616L (en)
WO (1) WO2004096180A1 (en)
ZA (1) ZA200508467B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100858508B1 (en) 2005-12-23 2008-09-12 주식회사 삼양사 Composition comprising azole antifungal drug and a preparation process thereof
MX2008015275A (en) * 2006-05-30 2009-02-06 Elan Pharma Int Ltd Nanoparticulate posaconazole formulations.
FR2922107B1 (en) * 2007-10-10 2010-02-26 Aventis Pharma Sa NEW TAXOID COMPOSITIONS
US20090238867A1 (en) * 2007-12-13 2009-09-24 Scott Jenkins Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
SI2722053T1 (en) * 2010-12-30 2018-02-28 Aktsionernoye Obshchestvo "Nauchnyi Tsentr Protivoninfektsionnyh Preparatov" Antibacterial agent for treating infectious diseases of bacterial origin
CN102085176A (en) * 2010-12-31 2011-06-08 江苏中丹制药有限公司 Nanometer itraconazole external preparation and preparation method and use thereof
CN102106832A (en) * 2011-02-12 2011-06-29 华中师范大学 Ketoconazole nanometer suspension freeze-dried powder and preparation method thereof
WO2017007957A1 (en) * 2015-07-07 2017-01-12 Mast Therapeutics, Inc. Reduced sodium poloxamer-188 formulations and methods for use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69914742T2 (en) * 1998-05-29 2004-11-25 Skyepharma Canada Inc., Verdun MICROPARTICLES PROTECTED AGAINST HEAT AND METHOD FOR TERMINAL STEAM STERILIZATION THEREOF
CN1174741C (en) * 1999-09-21 2004-11-10 Rtp药品公司 Surface modified particulate compositions of biologically active substances
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
DK1347747T3 (en) * 2000-12-22 2006-04-10 Baxter Int Process for treating submicroparticle suspensions of pharmaceutical agents
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix

Also Published As

Publication number Publication date
CA2523151A1 (en) 2004-11-11
BRPI0409929A (en) 2006-04-25
MXPA05011607A (en) 2005-12-15
KR20060015553A (en) 2006-02-17
EP1617818A1 (en) 2006-01-25
WO2004096180A1 (en) 2004-11-11
NO20055616L (en) 2006-01-25
AU2004234003A1 (en) 2004-11-11
ZA200508467B (en) 2006-09-27
JP2006525345A (en) 2006-11-09
CN1794975A (en) 2006-06-28

Similar Documents

Publication Publication Date Title
NO20055616D0 (en) Formulation that provides an antimicrobial drug that is effective against organisms that are normally resistant to the drug
DK1675462T3 (en) Synergistic insecticidal mixtures
ATE427658T1 (en) SYNERGISTIC INSECTICIDE MIXTURES
DK3494995T3 (en) SUPERFIN FORMOTHER FORMULATION
ATE389327T1 (en) HERBICIDE EFFECTIVE AGENT
NO20043702L (en) 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
DK1545467T3 (en) Solid pharmaceutical formulations comprising telmisartan
NO20031447L (en) Paclitaxel-based antitumor formulation
ATE524069T1 (en) SYNERGISTIC FUNGICIDE ACTIVE COMBINATIONS
ATE392813T1 (en) FUNGICIDAL ACTIVE COMBINATION
DK1660104T3 (en) Pharmaceutical formulation containing lanthanum compounds
DE60327306D1 (en) MODIFIED Russian
DK1498411T3 (en) Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
DK1830925T3 (en) ORAL PREPARATIONS CONTAINING BIPHENOL ANTIBACTERIAL COMPOUNDS
DK2125789T3 (en) Pyrimidinylpyrazoles as insecticidal and parasiticidal active substances
DE60334074D1 (en) CHEMICAL COMPOUND
ATE388703T1 (en) PHARMACEUTICAL FORMULATION OF TELMISARTAN SODIUM SALT
AP1959A (en) The use of N-arylhydrazine derivatives for combating pests
DE60315514D1 (en) HIGH-DOSED IBANDRONATE FORMULATION
DE602004002100D1 (en) SYNERGISTICALLY ACTIVE HERBICIDES MIXTURES
DE60325370D1 (en) SYNERGISTIC HERBICIDES COMPOSITIONS
DK1624869T3 (en) DOSAGE FORM CONTAINING PANTOPRAZOL AS ACTIVE INGREDIENT
PT102995B (en) PHARMACEUTICAL COMPOSITIONS WITH ANTIBIOTIC ACTIVITY
NO20043576L (en) Pharmaceutical formulation comprising melatonin
AR043327A1 (en) USE OF QUINURENINE 3- HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application